Physician profile
Aamir Cheema
NPI 1154388254
$51,242.62
in general payments reported to CMS, 2019-2025
18 companies · $978 in 2025
The $978 reported for 2025 was less than what a typical Clinical Cardiac Electrophysiology provider received nationally (typical 2025 total: $2,477).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $48K · 2020: $1,127 · 2021: $81.17 · 2022: $363 · 2023: $446 · 2024: $531 · 2025: $978.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,658 · Travel and Lodging: $297.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,658.02 |
| Travel and Lodging | $297.19 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $36,048.60 | 2019-2023 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $7,679.16 | 2019 | |
| Pfizer INC. | $4,667.25 | 2019-2023 | |
| Biosense Webster, INC. | $760.88 | 2021-2025 | Carto 3, Qdot Micro Catheter, Thermocool Sf |
| Boston Scientific Corporation | $561.80 | 2019-2025 | General - Therapies, Watchman Flx |
| E.R. Squibb & Sons, L.L.C. | $500.00 | 2019 | |
| Medtronic, INC. | $359.20 | 2024-2025 | Affera Mapping System, Linq II |
| Cvrx, INC. | $215.01 | 2022-2023 | Barostim Neo System |
| Inspire Medical Systems, INC. | $137.91 | 2025 | Inspire |
| Impulse Dynamics (USA) INC. | $103.18 | 2023 | Optimizer |
| Philips North America LLC | $92.68 | 2025 | Lm Undivided |
| Janssen Pharmaceuticals, INC | $57.87 | 2019-2022 | |
| Cardiva Medical, INC. | $17.15 | 2024 | Cardiva Vascade Mvp Vvcs 6-12f |
| Biotronik INC. | $14.91 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $13.89 | 2022 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Atricure, INC. | $13.13 | 2019 |
2 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Aamir Cheema listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.